Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | chorismate synthase | 0.0523 | 1 | 0.5 |
Plasmodium falciparum | chorismate synthase | 0.0523 | 1 | 0.5 |
Toxoplasma gondii | chorismate synthase, putative | 0.0523 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase) | 0.0258 | 0 | 0.5 |
Plasmodium vivax | chorismate synthase | 0.0523 | 1 | 0.5 |
Mycobacterium leprae | Chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase). | 0.0258 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 79 uM | Inhibitory activity against acyl-CoA:cholesterol O-acyltransferase (ACAT) | ChEMBL. | No reference |
IC50 (binding) | = 79 uM | Inhibitory activity against acyl-CoA:cholesterol O-acyltransferase (ACAT) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.